Oldest DNA Reveals Life in Greenland 2 Million Years Ago 

Professors Eske Willerslev and Kurt H. Kjaer expose fresh layers for sampling of sediments at Kap Kobenhavn, Greenland. (Svend Funder via AP)
Professors Eske Willerslev and Kurt H. Kjaer expose fresh layers for sampling of sediments at Kap Kobenhavn, Greenland. (Svend Funder via AP)
TT

Oldest DNA Reveals Life in Greenland 2 Million Years Ago 

Professors Eske Willerslev and Kurt H. Kjaer expose fresh layers for sampling of sediments at Kap Kobenhavn, Greenland. (Svend Funder via AP)
Professors Eske Willerslev and Kurt H. Kjaer expose fresh layers for sampling of sediments at Kap Kobenhavn, Greenland. (Svend Funder via AP)

Scientists discovered the oldest known DNA and used it to reveal what life was like 2 million years ago in the northern tip of Greenland. Today, it’s a barren Arctic desert, but back then it was a lush landscape of trees and vegetation with an array of animals, even the now extinct mastodon. 

“The study opens the door into a past that has basically been lost,” said lead author Kurt Kjær, a geologist and glacier expert at the University of Copenhagen. 

With animal fossils hard to come by, the researchers extracted environmental DNA, also known as eDNA, from soil samples. This is the genetic material that organisms shed into their surroundings — for example, through hair, waste, spit or decomposing carcasses. 

Studying really old DNA can be a challenge because the genetic material breaks down over time, leaving scientists with only tiny fragments. 

But with the latest technology, researchers were able to get genetic information out of the small, damaged bits of DNA, explained senior author Eske Willerslev, a geneticist at the University of Cambridge. In their study, published Wednesday in the journal Nature, they compared the DNA to that of different species, looking for matches. 

The samples came from a sediment deposit called the Kap København formation in Peary Land. Today, the area is a polar desert, Kjær said. 

But millions of years ago, this region was undergoing a period of intense climate change that sent temperatures up, Willerslev said. Sediment likely built up for tens of thousands of years at the site before the climate cooled and cemented the finds into permafrost. 

The cold environment would help preserve the delicate bits of DNA — until scientists came along and drilled the samples out, beginning in 2006. 

During the region's warm period, when average temperatures were 20 to 34 degrees Fahrenheit (11 to 19 degrees Celsius) higher than today, the area was filled with an unusual array of plant and animal life, the researchers reported. The DNA fragments suggest a mix of Arctic plants, like birch trees and willow shrubs, with ones that usually prefer warmer climates, like firs and cedars. 

The DNA also showed traces of animals including geese, hares, reindeer and lemmings. Previously, a dung beetle and some hare remains had been the only signs of animal life at the site, Willerslev said. 

One big surprise was finding DNA from the mastodon, an extinct species that looks like a mix between an elephant and a mammoth, Kjær said. 

Many mastodon fossils have previously been found from temperate forests in North America. That’s an ocean away from Greenland, and much farther south, Willerslev said. 

“I wouldn’t have, in a million years, expected to find mastodons in northern Greenland,” said Love Dalen, a researcher in evolutionary genomics at Stockholm University who was not involved in the study. 

Because the sediment built up in the mouth of a fjord, researchers were also able to get clues about marine life from this time period. The DNA suggests horseshoe crabs and green algae lived in the area — meaning the nearby waters were likely much warmer back then, Kjær said. 

By pulling dozens of species out of just a few sediment samples, the study highlights some of eDNA’s advantages, said Benjamin Vernot, an ancient DNA researcher at Germany’s Max Planck Institute for Evolutionary Anthropology who was not involved in the study. 

“You really get a broader picture of the ecosystem at a particular time,” Vernot said. “You don’t have to go and find this piece of wood to study this plant, and this bone to study this mammoth.” 

Based on the data available, it’s hard to say for sure whether these species truly lived side by side, or if the DNA was mixed together from different parts of the landscape, said Laura Epp, an eDNA expert at Germany’s University of Konstanz who was not involved in the study. 

But Epp said this kind of DNA research is valuable to show “hidden diversity” in ancient landscapes. 

Willerslev believes that because these plants and animals survived during a time of dramatic climate change, their DNA could offer a “genetic roadmap” to help us adapt to current warming. 

Stockholm University's Dalen expects ancient DNA research to keep pushing deeper into the past. He worked on the study that previously held the “oldest DNA” record, from a mammoth tooth around a million years old. 

“I wouldn’t be surprised if you can go at least one or perhaps a few million years further back, assuming you can find the right samples,” Dalen said. 



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”